Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i.v. dantrolene sodium. The prompt and satisfactory outcome after early diagnosis indicates that dantrolene should be considered a useful treatment in NMS.
D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000209:etiology
D016651:Lithium Carbonate; D008094:Lithium; D003620:Dantrolene; D006220:Haloperidol